Skip to main content
Erschienen in: International Ophthalmology 10/2023

05.06.2023 | Original Paper

Characteristics and outcomes of full-thickness macular holes created during vitrectomy for proliferative diabetic retinopathy

verfasst von: Mei-Chi Tsui, Chung-May Yang, Lu-Chun Wang

Erschienen in: International Ophthalmology | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the clinical features, management, and prognosis of full-thickness macular holes (FTMHs) inadvertently created during vitrectomy for eyes with proliferative diabetic retinopathy (PDR) and fibrovascular proliferation (FVP).

Methods

Eyes with PDR and FVP that had intraoperatively created FTMHs were retrospectively collected as the study group, and age- and sex-matched subjects with PDR and FVP who did not have intraoperative FTMHs were selected as the control group. Fundus abnormalities, optical coherence tomography (OCT) features, and anatomical and functional outcomes were compared between the two groups.

Results

Eleven eyes of 11 patients (5 male and 6 female) were identified as the study group. Follow-up duration was 36.8 ± 47.2 months. FTMHs were managed by ILM peeling or the inverted ILM flap technique. Anatomical success and MH closure were achieved in 100% of eyes in the study group. In comparison to the control group, the study group had a higher proportion of condensed prefoveal tissue (63.6% vs. 22.7%, p = 0.028), and a higher ratio of silicone oil tamponade (63.6% vs. 18.2%, p = 0.014), whereas there were no differences in preoperative and final BCVA, and the severity, activity, and locations of FVP between the two groups.

Conclusion

Condensed prefoveal tissue was a risk factor of FTMHs created during operation for eyes with PDR and FVP. The ILM peeling or the inverted ILM flap technique may be beneficial for the treatment with favorable anatomical and functional outcomes.
Literatur
1.
Zurück zum Zitat Garcia-Arumi J, Corcostegui B, Cavero L, Sararols L (1997) The role of vitreoretinal surgery in the treatment of posttraumatic macular hole. Retina 17(5):372–377CrossRefPubMed Garcia-Arumi J, Corcostegui B, Cavero L, Sararols L (1997) The role of vitreoretinal surgery in the treatment of posttraumatic macular hole. Retina 17(5):372–377CrossRefPubMed
3.
Zurück zum Zitat Kwok AK, Cheng LL, Gopal L, Sharma T, Lam DS (2000) Endolaser around macular hole in the management of associated retinal detachment in highly myopic eyes. Retina 20(5):439–444CrossRefPubMed Kwok AK, Cheng LL, Gopal L, Sharma T, Lam DS (2000) Endolaser around macular hole in the management of associated retinal detachment in highly myopic eyes. Retina 20(5):439–444CrossRefPubMed
5.
Zurück zum Zitat Tsui MC, Hsieh YT, Lai TT, Lai CT, Lin HC, Ho TC et al (2021) Full-thickness macular hole formation in proliferative diabetic retinopathy. Sci Rep 11(1):23839CrossRefPubMedPubMedCentral Tsui MC, Hsieh YT, Lai TT, Lai CT, Lin HC, Ho TC et al (2021) Full-thickness macular hole formation in proliferative diabetic retinopathy. Sci Rep 11(1):23839CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kase S, Saito W, Ohgami K, Yoshida K, Furudate N, Saito A et al (2007) Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Br J Ophthalmol 91(10):1376–1378CrossRefPubMedPubMedCentral Kase S, Saito W, Ohgami K, Yoshida K, Furudate N, Saito A et al (2007) Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Br J Ophthalmol 91(10):1376–1378CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Abu El-Asrar AM, Missotten L, Geboes K (2010) Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes. Clin Exp Ophthalmol 38(1):57–64CrossRefPubMed Abu El-Asrar AM, Missotten L, Geboes K (2010) Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes. Clin Exp Ophthalmol 38(1):57–64CrossRefPubMed
8.
Zurück zum Zitat Abu El-Asrar AM, Struyf S, Opdenakker G, Van Damme J, Geboes K (2010) Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Mol Vis 15(16):1098–1107 Abu El-Asrar AM, Struyf S, Opdenakker G, Van Damme J, Geboes K (2010) Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Mol Vis 15(16):1098–1107
9.
Zurück zum Zitat Iannetti L, Accorinti M, Malagola R, Bozzoni-Pantaleoni F, Da Dalt S, Nicoletti F et al (2011) Role of the intravitreal growth factors in the pathogenesis of idiopathic epiretinal membrane. Invest Ophthalmol Vis Sci 52(8):5786–5789CrossRefPubMed Iannetti L, Accorinti M, Malagola R, Bozzoni-Pantaleoni F, Da Dalt S, Nicoletti F et al (2011) Role of the intravitreal growth factors in the pathogenesis of idiopathic epiretinal membrane. Invest Ophthalmol Vis Sci 52(8):5786–5789CrossRefPubMed
10.
Zurück zum Zitat Shukla D, Dhoble P, Jager RD, Aiello LP, Ramasamy K (2006) Closure of macular hole following vitrectomy for diabetic tractional macular detachment. Eye (Lond) 20(12):1386–1388CrossRefPubMed Shukla D, Dhoble P, Jager RD, Aiello LP, Ramasamy K (2006) Closure of macular hole following vitrectomy for diabetic tractional macular detachment. Eye (Lond) 20(12):1386–1388CrossRefPubMed
12.
Zurück zum Zitat Yeh PT, Cheng CK, Chen MS, Yang CH, Yang CM (2009) Macular hole in proliferative diabetic retinopathy with fibrovascular proliferation. Retina 29(3):355–361CrossRefPubMed Yeh PT, Cheng CK, Chen MS, Yang CH, Yang CM (2009) Macular hole in proliferative diabetic retinopathy with fibrovascular proliferation. Retina 29(3):355–361CrossRefPubMed
13.
Zurück zum Zitat Chen SN, Yang CM (2018) Internal limiting membrane flaps for coexistent macular hole and retinal detachment in eyes with proliferative diabetic retinopathy. J Ophthalmol 2018:3470731CrossRefPubMedPubMedCentral Chen SN, Yang CM (2018) Internal limiting membrane flaps for coexistent macular hole and retinal detachment in eyes with proliferative diabetic retinopathy. J Ophthalmol 2018:3470731CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Karimov M, Akhundova L, Aliyeva T (2020) Pars plana vitrectomy for full-thickness macular holes in patients with proliferative diabetic retinopathy and active fibrovascular proliferation. Clin Ophthalmol 14:4125–4133CrossRefPubMedPubMedCentral Karimov M, Akhundova L, Aliyeva T (2020) Pars plana vitrectomy for full-thickness macular holes in patients with proliferative diabetic retinopathy and active fibrovascular proliferation. Clin Ophthalmol 14:4125–4133CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Babu N, Kohli P, Mishra C, Rajan RP, Kumar K, Ramasamy K et al (2021) Surgical outcome of full-thickness macular hole secondary to tractional retinal detachment in proliferative diabetic retinopathy. Indian J Ophthalmol 69(11):3302–3307CrossRefPubMedPubMedCentral Babu N, Kohli P, Mishra C, Rajan RP, Kumar K, Ramasamy K et al (2021) Surgical outcome of full-thickness macular hole secondary to tractional retinal detachment in proliferative diabetic retinopathy. Indian J Ophthalmol 69(11):3302–3307CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120(12):2611–2619CrossRefPubMed Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120(12):2611–2619CrossRefPubMed
19.
Zurück zum Zitat Su CC, Yang CH, Yeh PT, Yang CM (2014) Macular tractional retinoschisis in proliferative diabetic retinopathy: clinical characteristics and surgical outcome. Ophthalmologica 231(1):23–30CrossRefPubMed Su CC, Yang CH, Yeh PT, Yang CM (2014) Macular tractional retinoschisis in proliferative diabetic retinopathy: clinical characteristics and surgical outcome. Ophthalmologica 231(1):23–30CrossRefPubMed
20.
Zurück zum Zitat Tsui MC, Yang CM (2021) Early and late macular changes after the inverted internal limiting membrane flap technique for a full-thickness macular hole. Retina 41(1):20–28CrossRefPubMed Tsui MC, Yang CM (2021) Early and late macular changes after the inverted internal limiting membrane flap technique for a full-thickness macular hole. Retina 41(1):20–28CrossRefPubMed
21.
Zurück zum Zitat Henrich PB, Haritoglou C, Meyer P, Ferreira PR, Schotzau A, Katamay R et al (2010) Anatomical and functional outcome in brilliant blue G assisted chromovitrectomy. Acta Ophthalmol 88(5):588–593CrossRefPubMed Henrich PB, Haritoglou C, Meyer P, Ferreira PR, Schotzau A, Katamay R et al (2010) Anatomical and functional outcome in brilliant blue G assisted chromovitrectomy. Acta Ophthalmol 88(5):588–593CrossRefPubMed
22.
Zurück zum Zitat Henrich PB, Priglinger SG, Haritoglou C, Josifova T, Ferreira PR, Strauss RW et al (2011) Quantification of contrast recognizability during brilliant blue G- and indocyanine green-assisted chromovitrectomy. Invest Ophthalmol Vis Sci 52(7):4345–4349CrossRefPubMed Henrich PB, Priglinger SG, Haritoglou C, Josifova T, Ferreira PR, Strauss RW et al (2011) Quantification of contrast recognizability during brilliant blue G- and indocyanine green-assisted chromovitrectomy. Invest Ophthalmol Vis Sci 52(7):4345–4349CrossRefPubMed
23.
Zurück zum Zitat Sjaarda RN, Glaser BM, Thompson JT, Murphy RP, Hanham A (1995) Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology 102(9):1387–1392CrossRefPubMed Sjaarda RN, Glaser BM, Thompson JT, Murphy RP, Hanham A (1995) Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology 102(9):1387–1392CrossRefPubMed
24.
Zurück zum Zitat Al-Harthi E, Abboud EB, Al-Dhibi H, Dhindsa H (2005) Incidence of sclerotomy-related retinal breaks. Retina 25(3):281–284CrossRefPubMed Al-Harthi E, Abboud EB, Al-Dhibi H, Dhindsa H (2005) Incidence of sclerotomy-related retinal breaks. Retina 25(3):281–284CrossRefPubMed
25.
Zurück zum Zitat Ramkissoon YD, Aslam SA, Shah SP, Wong SC, Sullivan PM (2010) Risk of iatrogenic peripheral retinal breaks in 20-G pars plana vitrectomy. Ophthalmology 117(9):1825–1830CrossRefPubMed Ramkissoon YD, Aslam SA, Shah SP, Wong SC, Sullivan PM (2010) Risk of iatrogenic peripheral retinal breaks in 20-G pars plana vitrectomy. Ophthalmology 117(9):1825–1830CrossRefPubMed
26.
Zurück zum Zitat Dogramaci M, Lee EJ, Williamson TH (2012) The incidence and the risk factors for iatrogenic retinal breaks during pars plana vitrectomy. Eye (Lond) 26(5):718–722CrossRefPubMed Dogramaci M, Lee EJ, Williamson TH (2012) The incidence and the risk factors for iatrogenic retinal breaks during pars plana vitrectomy. Eye (Lond) 26(5):718–722CrossRefPubMed
27.
Zurück zum Zitat Figueroa MS, Ruiz-Moreno JM, Gonzalez F, del Valle A, Govetto C, de la Vega R, Plascencia N, Contreras I, Medina JL (2015) Long-term outcomes OF 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade for myopic traction maculopathy: a prospective study. Retina 35(9):1836–1843. https://doi.org/10.1097/IAE.0000000000000554CrossRefPubMed Figueroa MS, Ruiz-Moreno JM, Gonzalez F, del Valle A, Govetto C, de la Vega R, Plascencia N, Contreras I, Medina JL (2015) Long-term outcomes OF 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade for myopic traction maculopathy: a prospective study. Retina 35(9):1836–1843. https://​doi.​org/​10.​1097/​IAE.​0000000000000554​CrossRefPubMed
28.
Zurück zum Zitat Parolini B, Palmieri M, Finzi A, Besozzi G, Frisina R (2021) Myopic traction maculopathy: a new perspective on classification and management. Asia Pac J Ophthalmol (Phila) 10(1):49–59CrossRefPubMed Parolini B, Palmieri M, Finzi A, Besozzi G, Frisina R (2021) Myopic traction maculopathy: a new perspective on classification and management. Asia Pac J Ophthalmol (Phila) 10(1):49–59CrossRefPubMed
29.
Zurück zum Zitat Sawaguchi S, Maruko I, Mikami Y, Hasegawa T, Koizumi H, Iida T (2017) Macular hole formation identified with intraoperative oct during vitrectomy for vitreomacular traction syndrome. Retin Cases Brief Rep Fall 11(4):380–382CrossRef Sawaguchi S, Maruko I, Mikami Y, Hasegawa T, Koizumi H, Iida T (2017) Macular hole formation identified with intraoperative oct during vitrectomy for vitreomacular traction syndrome. Retin Cases Brief Rep Fall 11(4):380–382CrossRef
30.
31.
Zurück zum Zitat Michalewska Z, Nawrocki J (2021) Fovea morphology after vitrectomy in eyes with full-thickness macular hole coexisting with diabetic retinopathy. J Vitreoretin Dis 5(1):53–59CrossRefPubMed Michalewska Z, Nawrocki J (2021) Fovea morphology after vitrectomy in eyes with full-thickness macular hole coexisting with diabetic retinopathy. J Vitreoretin Dis 5(1):53–59CrossRefPubMed
32.
Zurück zum Zitat Imai M, Iijima H, Gotoh T, Tsukahara S (1999) Optical coherence tomography of successfully repaired idiopathic macular holes. Am J Ophthalmol 128(5):621–627CrossRefPubMed Imai M, Iijima H, Gotoh T, Tsukahara S (1999) Optical coherence tomography of successfully repaired idiopathic macular holes. Am J Ophthalmol 128(5):621–627CrossRefPubMed
33.
Zurück zum Zitat Michalewska Z, Michalewski J, Cisiecki S, Adelman R, Nawrocki J (2008) Correlation between foveal structure and visual outcome following macular hole surgery: a spectral optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol 246(6):823–830CrossRefPubMed Michalewska Z, Michalewski J, Cisiecki S, Adelman R, Nawrocki J (2008) Correlation between foveal structure and visual outcome following macular hole surgery: a spectral optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol 246(6):823–830CrossRefPubMed
34.
Zurück zum Zitat Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55(9):2401–2411CrossRefPubMed Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS et al (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55(9):2401–2411CrossRefPubMed
35.
Zurück zum Zitat King GL, Brownlee M (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25(2):255–270CrossRefPubMed King GL, Brownlee M (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25(2):255–270CrossRefPubMed
36.
Zurück zum Zitat Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatr 27(2):283–290CrossRef Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatr 27(2):283–290CrossRef
37.
Zurück zum Zitat Wilson DJ, Green WR (1987) Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am J Ophthalmol 103(2):167–179CrossRefPubMed Wilson DJ, Green WR (1987) Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am J Ophthalmol 103(2):167–179CrossRefPubMed
38.
Zurück zum Zitat Lecleire-Collet A, Muraine M, Menard JF, Brasseur G (2006) Evaluation of macular changes before and after successful retinal detachment surgery using stratus-optical coherence tomography. Am J Ophthalmol 142(1):176–179CrossRefPubMed Lecleire-Collet A, Muraine M, Menard JF, Brasseur G (2006) Evaluation of macular changes before and after successful retinal detachment surgery using stratus-optical coherence tomography. Am J Ophthalmol 142(1):176–179CrossRefPubMed
Metadaten
Titel
Characteristics and outcomes of full-thickness macular holes created during vitrectomy for proliferative diabetic retinopathy
verfasst von
Mei-Chi Tsui
Chung-May Yang
Lu-Chun Wang
Publikationsdatum
05.06.2023
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 10/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-023-02753-8

Weitere Artikel der Ausgabe 10/2023

International Ophthalmology 10/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.